ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

NTP Board Approves $4 Million Mouse Variation Concept

November 22, 1985

Also in this 8-page issue: Tony Hunter, Raymond DuBois win AACR Landon prizes.

March 5, 2004

NCI Told To “Cut Out The Nonsense,” Adequately Fund Programs At Centers Required By Mandates

November 5, 1976

Fewer Side Effects With IMRT Than Traditional Radiation

August 31, 2007

NCI Advisory Group, Other Cancer Meetings

February 24, 1984

In Brief: Cancer Act renewal, Appropriations Bill Caught In Squeeze Between Conventions

August 1, 1980